IQVIA Biotech Thought Leadership

  1. Virtual Approaches In Oncology Clinical Trials During COVID-19 And Onward 3/4/2021

    Patients living with cancer are among the most vulnerable during the pandemic, but sponsors and researchers understand oncology drug development must continue. This paper discusses how COVID-19 is driving change in the oncology trial landscape and how these insights may shape the future of post-pandemic clinical development.